All women who are in their
childbearing years should receive pre-pregnancy counseling for optimizing
metabolic
control prior to conception. Counseling for family planning is essential to
achieve this goal.
American Indian and Alaska
Native women are at
increased risk for developing gestational diabetes (GDM), as are women with
certain other risk factors, including but not limited to the following:
·
previous gestational diabetes ·
obesity
·
previous fetal macrosomia
· insulin resistance syndrome
·
unexplained stillbirth
·
polycystic ovarian syndrome (PCOS)
·
congenital anomaly
·
family history of diabetes
American
Indian and Alaska Native women should be screened for pre-existing diabetes early in pregnancy. If early screening is negative, a screen for GDM should be repeated
at 24-28 weeks gestation.
Women with GDM are at increased risk of developing
type 2 diabetes after delivery (about one third of all AI/AN women with GDM will develop
diabetes within 5 years). These
women should be re-tested by OGTT at least 6-12 weeks post delivery to determine
their glycemic status. Women with a
normal postpartum OGTT should be re-tested every 1-3 years.
Bear in mind that diagnostic standards for diabetes in breastfeeding
women have not been
All women with a history of GDM should receive counseling/education regarding lifestyle modifications that will reduce or delay the development of type 2 diabetes. Moreover, the importance of maintaining optimal glucose control prior to and during any subsequent pregnancy should be stressed. Mothers should be made aware that children of GDM pregnancies should be monitored for obesity and abnormalities of glucose utilization.
Further recommendations and
guidelines for the screening, diagnosis and treatment of GDM may be found in the
most recent Clinical Practice Recommendations of the American Diabetes
Association (published annually), Management of Diabetes in Pregnancy, 3rd
Edition (ADA), 2000, and Metzger BE, Coustan DR (Eds.): Proceedings of the
Fourth International Workshop-Conference on Gestational Diabetes Mellitus.
Diabetes Care 21 (Suppl. 2): B1-B167, 1998